rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Robert Mashal

Director

Company insider

Files Form 4 as: Director, Nuvation Bio.

In numbers

Trades disclosed
12
Buys
3
Sells
0
Bought
$624K
Sold
$0
Companies
1
Companies where not an officer
1
First trade
8 Jan 2024
Last trade
9 Jun 2026
Last filed
11 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
NUVB Nuvation BioDirector · Biotechnology · last 9 Jun 20263 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
9 Jun 2026filed 11 Jun 2026NUVB Nuvation BioBiotechnologySEC FORM 4 Bought$118K25,000 at $4.73filing
9 Jun 2026filed 11 Jun 2026NUVB Nuvation BioBiotechnologySEC FORM 4 Bought$118K25,000 at $4.73filing
21 May 2026filed 26 May 2026NUVB Nuvation Biooption or derivative · BiotechnologySEC FORM 4 Code A—123,397 at $0.00filing
21 May 2026filed 26 May 2026NUVB Nuvation Biooption or derivative · BiotechnologySEC FORM 4 Code A—123,397 at $0.00filing
11 Aug 2025filed 13 Aug 2025NUVB Nuvation Biooption or derivative · BiotechnologySEC FORM 4 Code G—350,001 at $0.00filing
11 Aug 2025filed 13 Aug 2025NUVB Nuvation Biooption or derivative · BiotechnologySEC FORM 4 Code G—350,001 at $0.00filing
21 May 2025filed 23 May 2025NUVB Nuvation Biooption or derivative · BiotechnologySEC FORM 4 Code A—292,983 at $0.00filing
1 Apr 2025filed 3 Apr 2025NUVB Nuvation BioBiotechnologySEC FORM 4 Bought$1,8371,100 at $1.67filing
1 Apr 2025filed 3 Apr 2025NUVB Nuvation BioBiotechnologySEC FORM 4 Bought$165K98,900 at $1.67filing
8 Oct 2024filed 10 Oct 2024NUVB Nuvation BioBiotechnologySEC FORM 4 Bought$4219 at $2.20filing
8 Oct 2024filed 10 Oct 2024NUVB Nuvation BioBiotechnologySEC FORM 4 Bought$220K99,981 at $2.20filing
8 Jan 2024filed 10 Jan 2024NUVB Nuvation Biooption or derivative · BiotechnologySEC FORM 4 Code A—741,179 at $0.00filing

News

Critical Review: Nuvation Bio (NYSE:NUVB) vs. OSR (NASDAQ:OSRH)NUVB · dailypolitical.com · 18 Oct 2026

0 headlines in the last 90 days name Robert Mashal; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care3

Buys in green, sells in red, by the company’s sector.

Related people

Gary HattersleyChief Scientific Officer · Chief Scientific Officer at Nuvation Bio, filing Form 4 there in the last year
Philippe SauvageChief Financial Officer · Chief Financial Officer at Nuvation Bio, filing Form 4 there in the last year
Kerry WentworthChief Regulatory Officer · Chief Regulatory Officer at Nuvation Bio, filing Form 4 there in the last year
Stacy MarkelChief People Officer · Chief People Officer at Nuvation Bio, filing Form 4 there in the last year
Kathryn E. FalbergDirector · Director at Nuvation Bio, filing Form 4 there in the last year